Hypertrophic
cardiomyopathy (HCM) is a thickening of the heart wall (typically the left
ventricle). The cause of HCM is a
genetic mutation of the cardiac sarcomere (cardiac muscle cell). The condition is described as obstructive
(70% of cases) and non-obstructive in nature.
The prevalence is 1 case in 500 – 1000 population and is the most common
genetic disorder of the heart. HCM is
one of the many (and the most common) cardiac conditions that can lead to
sudden cardiac arrest (SCA) in athletes.
Diagnosis of HCM in athletes is particularly challenging because
athletes tend to have larger hearts and ultimately a thicker left ventricle
wall because of their intense training and conditioning.
The most common signs and symptoms
for HCM include dysnea (difficulty breathing), angina, dizziness, palpitations,
and syncope (fainting). Unfortunately,
many times the conditions is asymptomatic and sudden cardiac death could be the
most dramatic and only symptom of HCM.
Sudden death from HCM typically occurs during or following strenuous
exercise.
RISK FACTORS
First degree risk factors:
-
Family
history of sudden cardiac death (<45 years old)
-
Recurrent
syncope (fainting)
-
Left
ventricle hypertrophy (LVH)
-
Abnormal
blood pressure response during exercise
For more factors, click HERE (see page
4).
DIAGNOSIS AND TREATMENT
If you would like more specific
information on the diagnosis and treatment guidelines for HCM, click HERE
for the standards published in November 2011 by the American Heart Association
(AHA) and the American College of Cardiology Foundation (ACCF).
CURRENT RESEARCH
The most recent information available
on the topic of HCM has been provided by researchers at Stanford
University. Researchers are investigating
the underlying causes of the genetic mutation of the cardiac sarcomere. Results of this study showed that calcium
dysregulation (calcium elevation) was likely to lead to HCM. Restoration of calcium homeostasis (balance)
prevented hypertrophy (enlargement of heart) and other physiological
irregularities. The authors are hopeful
that these finding can lead to improved and novel treatments for the
condition. Current treatment includes adapting
physical activities and in severe cases implantation of a pacemaker. To read the press regarding the study’s
publication and its potential implications, click HERE.
For other readings on HCM, check out
these links:
Submitted by Heather L. Clemons, MS, MBA, ATC
No comments:
Post a Comment